Miyaguchi M, Olofsson J, Hellquist H B
Department of Otolaryngology, Kagawa Medical School, Japan.
Acta Otolaryngol. 1990 Sep-Oct;110(3-4):309-13. doi: 10.3109/00016489009122553.
The immunoreactivity of epidermal growth factor receptor (EGFR) was studied in laryngeal biopsy specimens from 24 patients. The study comprised 5 cases of normal laryngeal mucosa, 5 cases of dysplasia, 7 cases of well differentiated squamous cell carcinoma, and 7 cases of poorly to moderately differentiated squamous cell carcinoma. EGFR was in general not expressed in normal and dysplastic epithelia, whilst all carcinomas showed a rather strong positive immunoreactivity. There was no significant difference in staining patterns between the well and poorly to moderately differentiated carcinomas. The results suggest that EGFR constitutes a component of neoplastic, but probably not preneoplastic, laryngeal disease. The study failed to reveal any difference in staining pattern between different types of laryngeal squamous cell carcinoma.
对24例患者的喉活检标本进行了表皮生长因子受体(EGFR)免疫反应性研究。该研究包括5例正常喉黏膜、5例发育异常、7例高分化鳞状细胞癌和7例低至中分化鳞状细胞癌。EGFR在正常和发育异常上皮中一般不表达,而所有癌均显示出较强的阳性免疫反应性。高分化癌与低至中分化癌之间的染色模式无显著差异。结果表明,EGFR是喉肿瘤性疾病而非癌前病变的一个组成部分。该研究未能揭示不同类型喉鳞状细胞癌之间染色模式的任何差异。